Merck teams up with Lupin on Indian vax marketing; Actelion hikes forecast as cost cuts kick in;

 @FiercePharma: Merck taps India's Lupin to market pneumococcal vax under new name. In U.S., brand = Pneumovax 23. More | Follow @FiercePharma

 @CarlyHFierce: Vivus holding its annual meeting this morning. Stay tuned for the end of the proxy fight with First Manhattan--and its outcome. | Follow @CarlyHFierce

> Merck ($MRK) tapped India's Lupin to help market its Pneumovax 23 vaccine in the country under a new brand name. Report

> Swiss drugmaker Actelion hiked its forecast after second-quarter sales topped estimates and cost cuts kicked in. Report

> Tax breaks enjoyed by Teva Pharmaceutical Industries ($TEVA) over the past several years could have created 40,000 jobs in Israel, a domestic business association alleges. Report

> Mylan ($MYL) said a court determined that Teva Pharmaceutical Industries had infringed its patent on the inhaled drug Perforomist. Release

> Roche ($RHHBY) launched a new test to allow more precise diagnosis of lung cancer. Report

Medical Device News

 @FierceMedDev: Alere's proxy fight gets personal in latest round. More | Follow @FierceMedDev

 @MarkHFierce: The clock is ticking. Send in your 2013 FMD Fierce 15 nominations. Submit now | Follow @MarkHFierce

 @DamianFierce: Quest dims revenue outlook as it sells stake in J&J cancer drug. Story | Follow @DamianFierce

> Ex-ArthroCare CEO, CFO finally indicted in $400M fraud scheme. Article

> Hungarian startup seeks med tech partner for intelligent cancer knife. Story

Biotech News

 @FierceBiotech: After Eylea win, Regeneron execs puzzle over R&D scale-up challenge. Article | Follow @FierceBiotech

 @JohnCFierce: Ensemble hasn't raised VC $$ since 2007--which is impressive. Funded by marquee collaborations. | Follow @JohnCFierce

 @EmilyMFierce: ICYMI: NIH confirms it's shelving India drug trials in wake of new regs. Editor's corner | Follow @EmilyMFierce

> Booming Alexion looks to Ensemble platform for ultra-rare disease programs. Article

> OncoMed extends the biotech IPO winning streak with $82M haul. News

Pharma Manufacturing News

 @EricPFierce: From FierceVaccines.com: ABC's appointment of Jenny McCarthy sparks media furor. News | Follow @EricPFierce

> UAE expects big growth in generic drug production. Item

> Penn Pharma to expand plant opened in May. Report

> China regulators pledge new crackdown on counterfeit drug operations. More

> J&J says it has upped its quality game across all 120 plants. Article

> Cispharma warning letter says injury investigation inadequate. Story

Vaccines News

> Gates-backed device extends cold chain to rural areas. Report

> Bio Farma taps Artes for VLP technology. Item

> ABC's appointment of Jenny McCarthy sparks media furor. More

> New data supports vaccinating gay men against HPV. Story

> Sanofi starts up dengue vaccine plant to maintain edge over Takeda. Article

And Finally... Signs of dementia may emerge earlier than previously thought, scientists say. Report

Suggested Articles

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.